Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

You may be eligible if

• 2. Within one month of registration on CALGB 8461, register onto a CALGB treatment study for previously untreated AML, ALL, MDS, or MM patients.
• 3. Simultaneously with registration on CALGB 8461, register patients within the continental United States onto CALGB 9665 (LTB).